In deep investigation of the complex relationship among mitochondrial activities, Lrrk2 mutations and DA D2 receptor activation will help identify specific pathogenetic hallmarks in PD useful to stratify patients who could benefit from dopaminergic therapy in order to delay disease presentation and progression. Here, LRRK2 is linked to Parkinson disease.